[1]
A. Saliha, D. Sucipto, M. C. Adella, and E. D. Perez, “Longitudinal MRI-PDFF Quantification of Hepatic Steatosis Reversibility During SGLT2-Inhibitor versus GLP-1 Receptor Agonist Therapy: A Prospective Cohort Study”, sjrir, vol. 3, no. 2, pp. 101-108, Jul. 2026.